← Open Payments lookup

NPI 1821464017: Open Payments

NPI 1821464017. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$174 in 3 payments from 2 companies in 2025. Trend: 2023 $92 · 2024 $313 · 2025 $174

Food & beverage: $174
CompanyPaymentsAmount
Alkermes, Inc.1$122
Neurocrine BioSciences, Inc.2$51

Products named: LYBALVI, INGREZZA.